Relationship between Changes in Thymic Emigrants and Cell-Associated HIV-1 Dna in HIV-1-Infected Children Initiating Antiretroviral Therapy

for the Paediatric European Network for Treatment of AIDS (PENTA)(Istituto Oncologico Veneto), Anita De Rossi(MRC Clinical Trials Unit at UCL), A. Sarah Walker(MRC Clinical Trials Unit at UCL), Davide De Forni, Nigel Klein(MRC Clinical Trials Unit at UCL), Diana M. Gibb(St Bartholomew's Hospital), J-P Aboulker(GlaxoSmithKline (Netherlands)), Abdel Babiker(GlaxoSmithKline (Netherlands)), Alexandra Compagnucci(GlaxoSmithKline (Netherlands)), J Darbyshire(GlaxoSmithKline (Netherlands)), Marianne Debré(GlaxoSmithKline (Netherlands)), Merril Gersten(GlaxoSmithKline (Netherlands)), Carlo Giaquinto(GlaxoSmithKline (Netherlands)), DM Gibb(St Bartholomew's Hospital), Annie S. K. Jones(GlaxoSmithKline (Netherlands)), J-P Aboulker(GlaxoSmithKline (Netherlands)), Abdel Babiker(GlaxoSmithKline (Netherlands)), Stéphane Blanche, A. B. Bohlin, Karina Butler(Medical Research Council), Guido Castelli Gattinara, Polly Clayden, J Darbyshire(GlaxoSmithKline (Netherlands)), M Debré(GlaxoSmithKline (Netherlands)), R de Groot, A. Faye, Carlo Giaquinto(GlaxoSmithKline (Netherlands)), DM Gibb(St Bartholomew's Hospital), C Griscelli(Medical Research Council), I. Grosch-Wörner, J Lévy(Medical Research Council), Hermione Lyall(Medical Research Council), M Mellado Pena(Medical Research Council), David Nadal, C. S. Peckham, JT Ramos Amador, Larry Luber Martínez Rosado, Cynthia Rudin(Medical Research Council), Henriëtte J. Scherpbier(Medical Research Council), Mike Sharland, Pier‐Angelo Tovo(Medical Research Council), Niels Henrik Valerius, Uwe Wintergerst, Charles A. Boucher(Medical Research Council), Mario Clerici(Istituto Oncologico Veneto), Anita De Rossi, Nigel Klein(Newham University Hospital), Clive Loveday(Medical Research Council), María Ángeles Muñoz‐Fernández(Medical Research Council), Deenan Pillay, C Rouzioux, Abdel Babiker(GlaxoSmithKline (Netherlands)), J Darbyshire(GlaxoSmithKline (Netherlands)), DM Gibb(St Bartholomew's Hospital), Lynda Harper(Medical Research Council), Denise F. Johnson, Peter Kelleher, L McGee(Newham University Hospital), Amy Poland(Medical Research Council), AS Walker(MRC Clinical Trials Unit at UCL), J-P Aboulker(GlaxoSmithKline (Netherlands)), Isabelle Carrière, Alexandra Compagnucci(GlaxoSmithKline (Netherlands)), M Debré(GlaxoSmithKline (Netherlands)), V. Eliette(Medical Research Council), Steven Leonardo, C Moulinier, Y Saïdi, Letizia Galli, A.B.M. Foot(Medical Research Council), H Kershaw(Ninewells Hospital), Owen Caul(Ninewells Hospital), W. Tarnow-Mordi, Jennifer Petrie, Peter McIntyre, K. Appleyard(Newham University Hospital), DM Gibb(St Bartholomew's Hospital), Vas Novelli(Newham University Hospital), Nigel Klein(Newham University Hospital), L McGee(Newham University Hospital), S. W. B. Ewen(Newham University Hospital), D.M. Johnson(St Bartholomew's Hospital), DM Gibb(St Bartholomew's Hospital), E.H. Cooper(St Bartholomew's Hospital), Timothy S. Fisher(St Bartholomew's Hospital), Rabiatu Barrie(Chelsea and Westminster Hospital), Jane E. Norman(Chelsea and Westminster Hospital), Darren King(University College London), E‐L Larsson‐Sciard(University College London)
Antiviral Therapy
January 1, 2005
Cited by 19Open Access
Full Text

Abstract

OBJECTIVES AND METHODS: To investigate the relationship between cell-associated HIV-1 dynamics and recent thymic T-cell emigrants, HIV-1 DNA and T-cell receptor rearrangement excision circles (TREC, a marker of recent thymic emigrants) were measured in peripheral blood mononuclear cells in 181 samples from 33 HIV-1-infected children followed for 96 weeks after antiretroviral therapy (ART) initiation. RESULTS: At baseline, HIV-1 DNA was higher in children with higher TREC (P=0.02) and was not related to age, CD4 or HIV-1 RNA in multivariate analyses (P>0.3). Overall, TREC increased and HIV-1 DNA decreased significantly after ART initiation, with faster HIV-1 DNA declines in children with higher baseline TREC (P=0.009). The greatest decreases in HIV-1 DNA occurred in children with the smallest increases in TREC levels during ART (P=0.002). However, this inverse relationship between changes in HIV-1 DNA and TREC tended to vary according to the phase of HIV-1 RNA decline (P=0.13); for the same increase in TREC, HIV-1 DNA decline was much smaller during persistent or transient viraemia compared with stable HIV-1 RNA suppression. CONCLUSIONS: Overall, these findings indicate that TREC levels predict HIV-1 DNA response to ART and suggest that immune repopulation by thymic emigrants adversely affects HIV-1 DNA decline in the absence of persistent viral suppression, possibly by providing a cellular source for viral infection and replication.


Related Papers

No related papers found

Powered by citation graph analysis